References

Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?

1959 · External reference

A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity

10.1182/blood.v15.2.212.212 · 1960 · External reference

The mode of action of a coagulation inhibitor of the blood of 2 patients with disseminated lupus erythematosus

10.1111/j.1365-2141.1964.tb00695.x · 1964 · External reference

An atypical circulating anticoagulant

10.1111/j.1600-0609.1966.tb00625.x · 1966 · External reference

The coagulation abnormalities in systemic lupus erythematosus

1968 · External reference

Incoagulability of the blood in systemic lupus erythematosus. A case due to hypoprothrombinemia and a circulating anticoagulant

10.1001/archpedi.1970.02100050367019 · 1970 · External reference

Acquired inhibitors in nonhemophilic patients

1974 · External reference

A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome

10.1182/blood.v61.4.684.684 · 1983 · External reference

Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors

10.1182/blood.v64.4.807.807 · 1984 · External reference

Anti-prothrombin antibodies and the lupus anticoagulant

10.1182/blood.v72.2.512.512 · 1988 · External reference

Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

10.1055/s-0038-1646476 · 1991 · External reference

Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles

10.1111/j.1365-2141.1993.tb04672.x · 1993 · External reference

Acquired hypoprothrombinemia due to nonneutralizing antibodies to prothrombin: mechanism and management

10.1182/blood.v65.6.1538.bloodjournal6561538 · 1985 · External reference

Antiphospholipid antibodies directed against a combination of phospholipid with prothrombin, protein C or protein S: an explanation for their pathogenetic mechanism?

10.1182/blood.v81.10.2618.2618 · 1993 · External reference

Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants

10.1055/s-0038-1649891 · 1995 · External reference

Autoantibodies to phospholipid-bindig plasma proteins in patients with thrombosis and phospholipid-reactive antibodies

10.1055/s-0038-1650355 · 1996 · External reference

Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies

10.1055/s-0038-1655994 · 1997 · External reference

Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin

10.1055/s-0038-1653838 · 1995 · External reference

Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men

10.1055/s-0038-1650296 · 1996 · External reference

Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus

10.1055/s-0038-1650686 · 1996 · External reference

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

10.1006/clin.1996.0089 · 1996 · External reference

High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men

10.1055/s-0038-1657711 · 1997 · External reference

Anticardiolipin, anti-β2-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of throbosis

1997 · External reference

Relationship of anti-β2-glycoprotein I and antiprothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies

1998 · External reference

Lupus anticoagulant, high levels of anticardiolipin, and anti-β2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension

1998 · External reference

Anti-prothrombin antibodies but not ‘pure’ anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome

1998 · External reference

Autoantibodies to human prothrombin and clinical manifestation in 207 patients with systemic lupus erythematosus

1998 · External reference

Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders

10.1046/j.1365-2141.1998.00876.x · 1998 · External reference

Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infections in thalassemia

10.1046/j.1365-2141.1998.00853.x · 1998 · External reference

Autoantibodies to prothrombin-phosphatidylserine complex: clinical significance in systemic lupus erythematosus

1998 · External reference